Published in Medical Letter on the CDC and FDA, May 11th, 2008
"CIMplicity(TM) was developed by UCB to enhance the Crohn's patient experience by providing comprehensive treatment support to patients receiving Cimzia(R)," said David Robinson,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.